Therapeutic Application of Botox for Treating Maxillofacial Disorders
Nalhar, Haryana, India, Haryana, India
ABSTRACT
The efficacy of Botox in facial aesthetics and cosmetics is well established over the period. Apart from facial cosmetics, the Botox is an answer to various maxillofacial muscular disorders.In this concern, Botox has been proven to be the most conservative and least invasive procedure for various dental disorders. It is commonly used to treatTemporomandibular disorder (TMD), Dental implants and surgery, Prominent gums, Masseteric hypertrophy, Mandibular spasm, Headache, migraine, and trigeminal neuralgia, Myofacial pain and neck pain, Bruxism and clenching cases, angular cheilitis and gummy smile, orthodontic relapse and depressed orthodontic appearance, for reducing muscle hyperactivity for retention of removable prosthodontics and many other dental problems.The present article reviews the current evidence pertaining to Botox use in the non-cosmetic head and neck dental disorders.
Key words:Botulinum toxin A, Bruxism, Temporomandibular joint disorders, Masticatory muscle hypertonicity
INTRODUCTION
Today is the age of minimal invasive dentistry where newest and finest techniques are continuously being devolved to provide maximum comfort and wellbeing to the patients. In this scenario, Botox is one of the most potent biological substances with minimal invasive approach for a number of dental conditions.
A number of factors, such as stress, hormones, diet, drugs, trauma, and certain neuromuscular diseases, can lead to an increase in sympathetic muscle tone, which results in masticatory muscle hypertonicity and parafunction.1 Dentists have traditionally attempted to treat and prevent this transient disease with methods that are expensive, risky, irreversible, and not evidence-based.1 There is a need for a conservative reversible non-invasive treatment that is quick, easy, relatively inexpensive, long acting, and effective. Masticatory muscle relaxation can be reliably achieved by injecting measured doses of botulinum toxin into specific sites in the major muscles of mastication.2The use of botulinum toxin offers the dentist an extremely effective tool to add to the armamentarium for treating conditions that derive from masticatory effective treatment for controlling the symptoms of masticatory muscle hypertonicity.3
Botox is a protein derived from clostridium botulinum bacteria, that has been known for its cosmetic and medical advantages.3 Botulinum can be absorbed from eyes, mucous membranes, respiratory tract or nonintact skin leading to toxicity botulism, a serious and life-threatening illness.4Kerner was the first one to reported its therapeutic use of botulinum toxin and coined the name botulism In 1897, Emile van found the producer of the botulin toxin was a bacterium, which he named clostridium botulinum.4,5
MECHANISM OF ACTION OF BOTOX
Botulinum toxin acts by binding pre-synaptically to high-affinity recognition sites on the cholinergic nerve terminals and decreasing the release of acetylcholine, causing a neuromuscular blocking effect (figure-1)6. On injecting to the affected muscle, it causes proteolysis of proteins Synaptosomal associated proteinSNAP-25 in the neuronal cytoplasm, which is very essential for therelease of acetyl choline at the neuromuscular junction.7This mechanism laid the foundation for the development of the toxin as a therapeutic tool where the results first appear in 1 to 3days, with peak in 1 to 4 weeks, and decline after 3 to 4 months.7
BOTOX AND DENTISTRY
Numerous maxillofacial disorders like Temporomandibular disorder (TMD), TMJ dislocation,Masseteric hypertrophy, Mandibular spasm, Dental implants and surgery, Prominent gums, headache, migraine, trigeminal neuralgia, Myofacial pain and neck pain, bruxism and pathological clenching, angular cheilitis, gummy smile, orthodontic relapse, depressed orthodontic appearance, for reducing muscle hyperactivity for retention of removable prosthodontics and many more conditions can be treated with appropriate amount of dose and correct site of injection.2,4,5,6,7
BOTOX APPLICATION IN MUSCULAR DISORDERS
Temporo-mandibular disorders: TMD is often with unclear etiology resulting in painful jaws and related musculature, headaches, migrane, cervical spine pain, ear pain and other mastication related problems.7Traditionally,NASIDS,muscle relaxants and treatments including orthotic devices, physiotherapyexercises, drug treatments (antidepressants), massage and acupuncture were used. A Botox injection targeting muscles of mastication brings improvement in painful symptoms in up to 90% of patients.7
Temporomandibular dislocation: Mandibular dislocation where condyle protrudes too far forward into the articulareminence and causes the jaw to lock in an openposition.Manual manipulation,which may require sedation or general anaesthesia generally been a method of treatment but Botox injection into lateralpterygoid muscles results in quick and long-lastingresults for a minimum of 3-4 months.7
Bruxism: This a muscular disorder arises withpsychological stress leading to nocturnally and diurnally grinding or clenching of teeth. Bruxism often lead to tooth wear, periodontal disease, headaches and TMJ disorders.8 The traditional treatment for bruxism has included intraoral appliances,behavioural modification and stress management. Botox has reported with more effective results where bilateral injection of Botox is given into the masseter and temporalis muscles or injected only into the masseter immediately superior to the angle of the mandible.8 The time duration of relief period ranges from 4-6 months or may show permanent relief from the problem.
Mandibular Spasm:The spasm of musclesof mastication and mandibular closing musculature where the musculature remains semi- contracted or in spasm, resulting in restrictedmouth opening, difficulty in eating and maintaining daily oral hygiene. Patients with mandibular spasms treated with BT injections have respondedpositively with symptomatic relief.9
Sialorrhea: The drooling of saliva is there, may be result of excess salivaproduction or the inability to hold saliva within themouth or swallow. This condition can be treated efficiently with Botox injection into parotid, sub-mandibular gland or both with dosage of toxin varied from 10-100 units, which resulted in reduction in salivaproduction and effect lasted for 1.5 to 6 months.2,10
Masseteric hypertrophy:Increased size of masseter muscles is evident in thepatient’s facial appearance where the jawappearsswollen and taut.Injection of small dose of Botox into the masseter muscles resulted in a sustainedreduction of masseter hyperactivity.11
AESTHETIC DENTISTRY AND BOTOX
Gummy smile/ Prominent gums:The excessive maxillary gingival tissue display upon smiling is most common aesthetic concern of the patients. Earlier only surgical correction of the hyper functional lip elevator muscles was considered to be effective but with many other side effects like scar contraction and relapses. Mostly gummy smile is due to hyper functional upper lip elevatormuscles that can be treated with minimally invasive Botox thatlimits muscular over contraction. These muscles can be proportionately weakenedwith Botox, which will reduce exposure of the upper gums while smiling.
Black triangle offers most challenging aestheticconcern after placing crowns, bridges or implants in anterior aesthetic zone. By injecting Botox into these areas, papilla plumps up and fill the space creating the black triangles. Morepleasing gingival contours can be achieved with just one injection of Botox.12
Asymmetrical Smiles: Facial asymmetries may be acquired facial asymmetry resulting from medical or physical accident, Parotidectomy or other surgeries causing injury to the facial. An injection of Botox into the overactive muscle fibres of depressor labii inferiororisproduces relaxation of the muscle resulting in a symmetrical smile.12,13
Salivary Fistula: The formation of a salivary fistula is a common complication following the surgical removal of parotid tumor. Though most of fistulae close spontaneously whereas some may actually cause facial deformity.An injection of Botox in the proximity of the parotid glands results in blockage of the parotid secretion. This causes a decrease in salivary flow,followed by glandular atrophy, allowing the salivary fistula to eventually heal.10
Dental implants and maxillofacial fractures: Muscle hyperactivity leads to excessive functional forces on teeth, prosthesis or implants in patient mouth. The overloadingof implant results in its failure along with impeding fracture callus formation after maxillofacialfracture fixation. Hence in both conditions muscular relaxationcan be achieved with Botox injections into the masticatory musclesallowing a more stable environment for implant integration and fracturehealing.14
NEURALGIAS AND BOTOX
Chronic Migraine:Chronic migraine is a disorder with resulting reduced qualityof life associated with discomfort. Botulinum toxin can be usedto treat this disorder.15
Trigeminal Neuralgia:It is a unilateral neurological disorder affecting orofacialmuscles leading to acute severe pain. Botox can be used as anadjunctive treatment modality in these patients which acts onnerve endings, thereby reducing the severity of the pain.15
Side Effects of Botox Injections
- Mild pain with injection leading to sore muscles, local edema and tenderness
- Temporary partial weakening of the musclesinjected
- Longer use of Botox may cause atrophyof the muscles injected
- Mild nausea with flu-like symptoms, palpitations or tingling sensations.16
CONCLUSION
Botulinum has proven to be an elixir that provides an overall conservative, minimal invasive,quick and painless approach. Botox has emerged as an alternative to surgeries,medications, or participation in behavioural modifications to relieve their muscle pains. In India, the use of Botox is still not in practice in Dental clinics but with everyday advancement in Dentistry, Botox will surly make its place. However, there are still research going on to cater more dental and medical problems with Botox.
REFERENCES
- Bansal A, Jain M, Joshi M, Agarwal D. Botox in Dentistry: The Healing Side of a Poison. J Adv Med Dent Scie 2014;2(1):95-99.
- Freund B, Schwartz M, Symington JM. Botulinum toxin: New treatment for temporomandibular disorders. Br J Oral Maxillofac Surg. 2000; 38:466–71.
- Erbguth FJ. Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov Disord. 2004 Mar;19 Suppl 8:S2-6.
- Clostridium Botulinum- Public health agency of Canada. Phac-aspc.gc.ca (201104-19). Retrieved on 2012-05-06 Blumenfeld A. Botulinum toxin type A in the treatment of Dental conditions. Inside Dent 2007; 2:1-5.
- Govindaraju et al.: Botox-upcoming therapeutic tool in Dental Practice.J Young Pharm, 2016; 8(1): 2-5.
- https://www.botoxmedical.com/FocalSpasticity/Efficacy/MechanismOfAction
- Kukreja R, Singh B. "Botulinum neurotoxins: structure and mechanism of action". Microbial toxins: current research and future trends. 2009; 15(4):224-27.
- Lee KM, Chow J, Hui E, Li W. botulinium type A injections for the managementof myofascial temeromandibular pain disorders. Asian J Oral Maxillofacial Surg.2005; 17:100–3.
- Tan EK, Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc 2000;131(2):211-6.
- Auger RG, Litchy WJ, Cascino TL, Ahlskog JE. Hemimasticatory spasm: Clinicaland electrophysiologic observations. Neurology 1992; 42:2263-6.
- Fuster-Torres MA, Berini-Aytés L, Gay-Escoda C. Salivary gland application ofbotulinum toxin for the treatment of sialorrhea. Med Oral Patol Oral Cir Bucal.2007;12: E511–7.
- Al-Ahmad HT, Al-Qudah MA. The treatment of masseter hypertrophy withbotulinum toxin type A. Saudi Med J 2006; 27:397-400.
- PoloM. Botulinum toxin type A in the treatment of excessive gingival display.Am J OrthodDentofacialOrthop. 2005; 127:214–8.
- Sinha A, Hurakadli M, Yadav P. Botox and derma fillers: The twin face of cosmetic dentistry. Int J Contemp Dent Med Rev 2015:10.157-60.
- BhogalPS, Hutton A, MonaghanA.Review of the current uses of Botox fordentally-related procedures. Dental Update April 2006;33(3):165-168.
- Chandra S, Devi MP, Ravindra SV, Singh D, Kumar S. Botoxonomics: A palliativeprick. Int J Sci Stud 2014; 2(6):108-111.
Disclaimer from Guident
The views and opinions expressed in articles published in Guident are solely those of the authors and do not necessarily reflect the views of the editors, the editorial board or the publisher, Ivory India. Guident does not endorse any product, technique or treatment described. Clinical content is intended for qualified dental and medical professionals and is not a substitute for individual clinical judgement. Guident, its editors and the publisher accept no liability for any consequence arising from the use of information published in the journal.
How to cite this article
Dr. Monika Malik Vigarniya Shaheed Hasan Khan Mewati Goverment Medical College, Dr. Manu Rathee Post Graduate Institute of Dental Science Rohtak. Therapeutic Application of Botox for Treating Maxillofacial Disorders. Guident. 2017 Dec;11(1). Available from: https://ivoryindia.in/articles/general/therapeutic-application-of-botox-for-treating-maxillofacial-disorders.html







